cepharanthine has been researched along with Cancer of Liver in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, F; Li, L; Pan, L; Wang, C; Wu, J; Xu, H; Xu, K; Yang, L | 1 |
| Fan, JL; Huang, ZX; Su, GF; Wang, Y; Wang, YF; Wang, ZG; Zhou, PJ | 1 |
| Cai-Hong, Z; Fang, M; Jin-Hua, J; Li, H; Ning, W; Qing-Duan, W; Xiao-Juan, G; Yan, Z | 1 |
| Fukumoto, M; Hata, K; Nakajima, A; Taura, K; Uchinami, H; Yamamoto, Y; Yamaoka, Y; Yonezawa, K | 1 |
| Biswas, KK; Hashiguchi, T; Kawahara, K; Maruyama, I; Sarker, KP; Tancharoen, S; Tancharon, S | 1 |
5 other study(ies) available for cepharanthine and Cancer of Liver
| Article | Year |
|---|---|
Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis
Topics: Amino Acids; Animals; Apoptosis; Benzylisoquinolines; Carcinogenesis; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Liver Neoplasms; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Random Allocation | 2021 |
Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC).
Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Autophagy; Benzylisoquinolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitophagy; Molecular Targeted Therapy; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Xenograft Model Antitumor Assays | 2020 |
Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cyclosporine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescent Dyes; Fluorouracil; Humans; Indicators and Reagents; Liver Neoplasms; Mice; Rhodamine 123; Tumor Cells, Cultured; Verapamil; Xenograft Model Antitumor Assays | 2011 |
Beneficial effect of cepharanthine on overcoming drug-resistance of hepatocellular carcinoma.
Topics: Adenosine Triphosphatases; Aged; Alkaloids; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Coloring Agents; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Immunohistochemistry; Inhibitory Concentration 50; Kinetics; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt.
Topics: Alkaloids; Animals; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Benzylisoquinolines; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Line, Tumor; Collagen Type XI; Cytochromes c; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2006 |